After3 years in the making, the Joint Clinical Assessment for the EU is in effect.
From 12th January 2025 new cancer medicines and advanced therapy medicinal products (ATMPs) will require a JCA across all 27 member states.
Join Owen and Georgie, along with guests Darren Callanan and Sam Morrison to discuss the main talking points of the JCA, and what to look out for when dealing with the new regulations.
Information
- Show
- FrequencyUpdated Bimonthly
- PublishedJanuary 13, 2025 at 12:34 PM UTC
- Length25 min
- RatingClean